200 related articles for article (PubMed ID: 29350351)
1. Convection-enhanced delivery of cetuximab conjugated iron-oxide nanoparticles for treatment of spontaneous canine intracranial gliomas.
Freeman AC; Platt SR; Holmes S; Kent M; Robinson K; Howerth E; Eagleson J; Bouras A; Kaluzova M; Hadjipanayis CG
J Neurooncol; 2018 May; 137(3):653-663. PubMed ID: 29350351
[TBL] [Abstract][Full Text] [Related]
2. Convection-Enhanced Delivery of Polymeric Nanoparticles Encapsulating Chemotherapy in Canines with Spontaneous Supratentorial Tumors.
Young JS; Bernal G; Polster SP; Nunez L; Larsen GF; Mansour N; Podell M; Yamini B
World Neurosurg; 2018 Sep; 117():e698-e704. PubMed ID: 29960096
[TBL] [Abstract][Full Text] [Related]
3. Targeted therapy of glioblastoma stem-like cells and tumor non-stem cells using cetuximab-conjugated iron-oxide nanoparticles.
Kaluzova M; Bouras A; Machaidze R; Hadjipanayis CG
Oncotarget; 2015 Apr; 6(11):8788-806. PubMed ID: 25871395
[TBL] [Abstract][Full Text] [Related]
4. Radiosensitivity enhancement of radioresistant glioblastoma by epidermal growth factor receptor antibody-conjugated iron-oxide nanoparticles.
Bouras A; Kaluzova M; Hadjipanayis CG
J Neurooncol; 2015 Aug; 124(1):13-22. PubMed ID: 25981803
[TBL] [Abstract][Full Text] [Related]
5. Safety and feasibility of the NanoKnife system for irreversible electroporation ablative treatment of canine spontaneous intracranial gliomas.
Rossmeisl JH; Garcia PA; Pancotto TE; Robertson JL; Henao-Guerrero N; Neal RE; Ellis TL; Davalos RV
J Neurosurg; 2015 Oct; 123(4):1008-25. PubMed ID: 26140483
[TBL] [Abstract][Full Text] [Related]
6. Canine spontaneous glioma: a translational model system for convection-enhanced delivery.
Dickinson PJ; LeCouteur RA; Higgins RJ; Bringas JR; Larson RF; Yamashita Y; Krauze MT; Forsayeth J; Noble CO; Drummond DC; Kirpotin DB; Park JW; Berger MS; Bankiewicz KS
Neuro Oncol; 2010 Sep; 12(9):928-40. PubMed ID: 20488958
[TBL] [Abstract][Full Text] [Related]
7. Superselective intraarterial cerebral infusion of cetuximab after osmotic blood/brain barrier disruption for recurrent malignant glioma: phase I study.
Chakraborty S; Filippi CG; Wong T; Ray A; Fralin S; Tsiouris AJ; Praminick B; Demopoulos A; McCrea HJ; Bodhinayake I; Ortiz R; Langer DJ; Boockvar JA
J Neurooncol; 2016 Jul; 128(3):405-15. PubMed ID: 26945581
[TBL] [Abstract][Full Text] [Related]
8. Naturally Occurring Canine Glioma as a Model for Novel Therapeutics.
Hubbard ME; Arnold S; Bin Zahid A; McPheeters M; Gerard O'Sullivan M; Tabaran AF; Hunt MA; Pluhar GE
Cancer Invest; 2018; 36(8):415-423. PubMed ID: 30234401
[TBL] [Abstract][Full Text] [Related]
9. Association of magnetic resonance imaging-based preoperative tumor volume with postsurgical survival time in dogs with primary intracranial glioma.
MacLellan JD; Arnold SA; Dave AC; Hunt MA; Pluhar GE
J Am Vet Med Assoc; 2018 Jan; 252(1):98-102. PubMed ID: 29244602
[TBL] [Abstract][Full Text] [Related]
10. Intratumoral temozolomide in spontaneous canine gliomas: feasibility of a novel therapy using implanted microcylinders.
Hicks J; Platt S; Stewart G; Senneca C; Holmes S; Kent M; Howerth E; Kaplan J; Kaplan E
Vet Med Sci; 2019 Feb; 5(1):5-18. PubMed ID: 30394686
[TBL] [Abstract][Full Text] [Related]
11. Preclinical evaluation of convection-enhanced delivery of liposomal doxorubicin to treat pediatric diffuse intrinsic pontine glioma and thalamic high-grade glioma.
Sewing ACP; Lagerweij T; van Vuurden DG; Meel MH; Veringa SJE; Carcaboso AM; Gaillard PJ; Peter Vandertop W; Wesseling P; Noske D; Kaspers GJL; Hulleman E
J Neurosurg Pediatr; 2017 May; 19(5):518-530. PubMed ID: 28291423
[TBL] [Abstract][Full Text] [Related]
12. Phase I trial of convection-enhanced delivery of IL13RA2 and EPHA2 receptor targeted cytotoxins in dogs with spontaneous intracranial gliomas.
Rossmeisl JH; Herpai D; Quigley M; Cecere TE; Robertson JL; D'Agostino RB; Hinckley J; Tatter SB; Dickinson PJ; Debinski W
Neuro Oncol; 2021 Mar; 23(3):422-434. PubMed ID: 32812637
[TBL] [Abstract][Full Text] [Related]
13. Effects of convection-enhanced delivery of bevacizumab on survival of glioma-bearing animals.
Wang W; Sivakumar W; Torres S; Jhaveri N; Vaikari VP; Gong A; Howard A; Golden EB; Louie SG; Schönthal AH; Hofman FM; Chen TC
Neurosurg Focus; 2015 Mar; 38(3):E8. PubMed ID: 25727230
[TBL] [Abstract][Full Text] [Related]
14. Convection-enhanced Delivery of Therapeutics for Malignant Gliomas.
Saito R; Tominaga T
Neurol Med Chir (Tokyo); 2017 Jan; 57(1):8-16. PubMed ID: 27980285
[TBL] [Abstract][Full Text] [Related]
15. Convection-enhanced delivery of topotecan into diffuse intrinsic brainstem tumors in children.
Anderson RC; Kennedy B; Yanes CL; Garvin J; Needle M; Canoll P; Feldstein NA; Bruce JN
J Neurosurg Pediatr; 2013 Mar; 11(3):289-95. PubMed ID: 23240851
[TBL] [Abstract][Full Text] [Related]
16. Convection-enhanced delivery of SN-38-loaded polymeric micelles (NK012) enables consistent distribution of SN-38 and is effective against rodent intracranial brain tumor models.
Zhang R; Saito R; Mano Y; Sumiyoshi A; Kanamori M; Sonoda Y; Kawashima R; Tominaga T
Drug Deliv; 2016 Oct; 23(8):2780-2786. PubMed ID: 26330269
[TBL] [Abstract][Full Text] [Related]
17. Survival times in dogs with presumptive intracranial gliomas treated with oral lomustine: A comparative retrospective study (2008-2017).
Moirano SJ; Dewey CW; Wright KZ; Cohen PW
Vet Comp Oncol; 2018 Dec; 16(4):459-466. PubMed ID: 29797768
[TBL] [Abstract][Full Text] [Related]
18. Comparison of linear and volumetric criteria for the determination of therapeutic response in dogs with intracranial gliomas.
Garcia Mora JK; Robertson J; Hsu FC; Shinn RL; Larson MM; Rylander CG; Whitlow CT; Debinski W; Davalos RV; B Daniel G; Rossmeisl JH
J Vet Intern Med; 2022 May; 36(3):1066-1074. PubMed ID: 35274379
[TBL] [Abstract][Full Text] [Related]
19. Convection-enhanced delivery and in vivo imaging of polymeric nanoparticles for the treatment of malignant glioma.
Bernal GM; LaRiviere MJ; Mansour N; Pytel P; Cahill KE; Voce DJ; Kang S; Spretz R; Welp U; Noriega SE; Nunez L; Larsen GF; Weichselbaum RR; Yamini B
Nanomedicine; 2014 Jan; 10(1):149-57. PubMed ID: 23891990
[TBL] [Abstract][Full Text] [Related]
20. Convection-enhanced delivery of boronated epidermal growth factor for molecular targeting of EGF receptor-positive gliomas.
Yang W; Barth RF; Adams DM; Ciesielski MJ; Fenstermaker RA; Shukla S; Tjarks W; Caligiuri MA
Cancer Res; 2002 Nov; 62(22):6552-8. PubMed ID: 12438250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
